Rouleau, Jean L.

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., Landmesser, U., López-Jaramillo, P., Manvelian, G., Pordy, R., et al. (2021) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 150

The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins

Blais, C., Marceau, F., Rouleau, J.-L., & Adam, A. (2000) · Peptides

Coagulation, Bradykinin, Polyphosphates, and AngioedemaPineapple and bromelain studies

Cited by 135

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.

Duan, Q. L., Nikpoor, B., Dubé, M.-P., Molinaro, G., Meijer, I. A., Dion, P., Rochefort, D., Saint-Onge, J., Flury, L., Brown, N. J., et al. (2005) · The American Journal of Human Genetics

Coagulation, Bradykinin, Polyphosphates, and AngioedemaRenin-Angiotensin System Studies

Cited by 126

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 118

Care Gaps in Adherence to Heart Failure Guidelines

Jarjour, M., Henri, C., de Denus, S., Fortier, A., Bouabdallaoui, N., Nigam, A., O’Meara, E., Ahnadi, C., White, M., Garceau, P., et al. (2020) · JACC: Heart Failure

Heart Failure Treatment and ManagementCardiac pacing and defibrillation studies

Cited by 105

Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema

Blais, C., Rouleau, J.-L., Brown, N. J., Lepage, Y., Spence, D., Munoz, C., Friborg, J., Geadah, D., Gervais, N., & Adam, A. (1999) · Immunopharmacology

Coagulation, Bradykinin, Polyphosphates, and AngioedemaRenin-Angiotensin System Studies

Cited by 78

Worsening Renal Function and Outcome in Heart Failure Patients with Reduced and Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment: Data from the CHARM-Study Programme

Damman, K., Solomon, S. D., Pfeffer, M. A., Swedberg, K., Yusuf, S., Young, J. B., Rouleau, J. L., Granger, C. B., & McMurray, J. J. V. (2016) · European Journal of Heart Failure

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 75

Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction

Docherty, K. F., Shen, L., Castagno, D., Petrie, M. C., Abraham, W. T., Böhm, M., Desai, A. S., Dickstein, K., Køber, L. V., Packer, M., et al. (2020) · European Journal of Heart Failure

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 42

Health‐related quality of life outcomes in PARAGON‐HF

Chandra, A., Polanczyk, C. A., Claggett, B. L., Vaduganathan, M., Packer, M., Lefkowitz, M. P., Rouleau, J. L., Liu, J., Shi, V. C., Schwende, H., et al. (2022) · European Journal of Heart Failure

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 33

Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial

De Marco, C., Claggett, B. L., de Denus, S., Zile, M. R., Huynh, T., Desai, A. S., Sirois, M. G., Solomon, S. D., Pitt, B., Rouleau, J. L., et al. (2021) · ESC Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 29

Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial

MacDonald, M. R., She, L., Doenst, T., Binkley, P. F., Rouleau, J. L., Tan, R.-S., Lee, K. L., Miller, A. B., Sopko, G., Szalewska, D., et al. (2015) · European Journal of Heart Failure

Cardiac and Coronary Surgery TechniquesCardiovascular Function and Risk Factors

Cited by 24

Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction

Basmadjian, L., Bouabdallaoui, N., Simard, F., O'Meara, E., Ducharme, A., Rouleau, J.-L., Racine, N., White, M., Sirois, M. G., Asgar, A., et al. (2023) · The American Journal of Cardiology

GDF15 and Related BiomarkersCardiac Valve Diseases and Treatments

Cited by 6